--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q140.560M / 11.667M--
Coinbase
COIN
Meta Platforms
META
Apple
AAPL
Amazon
AMZN
MicroStrategy
MSTR
US Stock MarketDetailed Quotes
ZNTL Zentalis Pharmaceuticals
- 3.390
- -0.270-7.38%
Trading Dec 3 10:34 ET
241.59MMarket Cap-1356P/E (TTM)
3.630High3.350Low257.30KVolume3.620Open3.660Pre Close878.09KTurnover0.46%Turnover RatioLossP/E (Static)71.27MShares18.07052wk High0.68P/B188.50MFloat Cap2.66052wk Low--Dividend TTM55.61MShs Float87.190Historical High--Div YieldTTM7.65%Amplitude2.660Historical Low3.412Avg Price1Lot Size
Zentalis Pharmaceuticals Key Stats
Zentalis Pharmaceuticals Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Zentalis Pharmaceuticals Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data